HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Montaner, L. J. Articles by Gordon, S. Search for Related Content PubMed PubMed Citation Articles by Montaner, L. J. Articles by Gordon, S. Agricola Articles by Montaner, L. J. Articles by Gordon, S.

Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, U.K.

Interleukin-10 (IL-10), a product of T lymphocytes, B cells and macrophages, participates in Th-2 immune responses and modulates macrophage functions including possible interactions with pathogens. We have found that Chinese hamster ovary cell-derived human recombinant (hr) IL-10 inhibits human immunodeficiency virus type 1 strains Ada and Ba-L (HIV-1_ADA and HIV-1_Ba-L) replication in primary tissue culture-derived macrophages in a dose-dependent manner. Inhibition by IL-10 treatment (> 5 U/ml) was effective 72 h before or 24 h after infection and cytokine activity blocked by anti-hrIL-10 antibody (19F1), or lost after heat inactivation of IL-10. Viral production was measured by determining p24 and reverse transcriptase levels while reverse transcription kinetics for the long terminal repeat (LTR) and gag were assessed at timed intervals after infection and quantified by ³²P end-labelling. IL-10 inhibited early steps of infection without modulating cell surface CD4⁺ levels. The onset of LTR reverse transcription was delayed by 4 to 8 h and the number of LTR transcripts was decreased by 77% at 24 h and by 87% 48 h after infection. IL-10 effects were reversible; after cytokine washout, cells treated before infection showed lower levels of virus compared with those treated after infection. IL-10 biological activity was confirmed in three virus-independent assays. These results demonstrate IL-10 decreases HIV-1 reverse transcription upon macrophage infection and subsequently mediates viral latency in vitro. Therefore, IL-10 may be involved in the effective control of HIV-1-infected macrophages in vivo.

Received 18 July 1994; accepted 16 August 1994.

This article has been cited by other articles:

				P. Ancuta, Y. Bakri, N. Chomont, H. Hocini, D. Gabuzda, and N. Haeffner-Cavaillon Opposite Effects of IL-10 on the Ability of Dendritic Cells and Macrophages to Replicate Primary CXCR4-Dependent HIV-1 Strains J. Immunol., March 15, 2001; 166(6): 4244 - 4253. [Abstract] [Full Text] [PDF]

				G. M. Graziani-Bowering and L. G. Filion Down Regulation of CD4 Expression following Isolation and Culture of Human Monocytes Clin. Vaccine Immunol., March 1, 2000; 7(2): 182 - 191. [Abstract] [Full Text] [PDF]

				M.-L. Wong, P. B. Bongiorno, V. Rettori, S. M. McCann, and J. Licinio Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications PNAS, January 7, 1997; 94(1): 227 - 232. [Abstract] [Full Text] [PDF]

				L. Montaner and S Gordon TH2 downregulation of macrophage HIV-1 replication Science, January 27, 1995; 267(5197): 538 - 539. [PDF]